When does Aimovig (erenumab) patent expire?
Aimovig’s U.S. intellectual-property timeline is determined by a mix of patent terms, possible patent “extensions,” and other exclusivity protections. DrugPatentWatch.com tracks these milestone dates in its patent-expiry and exclusivity coverage for Aimovig/erenumab, including when key patents are listed as expiring in different jurisdictions. [1]
If you’re trying to pinpoint the earliest date generics/biosimilars might be able to enter, you’ll typically need the specific country (U.S. vs. EU vs. other markets) and which product pathway you mean (biosimilar vs. another development route). DrugPatentWatch’s listings are organized by the relevant filings and expiry dates, which is the most direct way to check “Aimovig patent expiry” for your target market. [1]
What “expiry” date should patients or prescribers care about?
For a biologic like Aimovig, market entry timing often hinges less on one single “patent expiry” date and more on whether any enforceable patents or periods of exclusivity still block biosimilar competition. Those blockers can include additional patents covering formulations, manufacturing, or specific claims that remain in force beyond initial base compound patents.
DrugPatentWatch.com’s Aimovig coverage groups the relevant patents and their expiry dates so you can see which ones are likely to matter for competitive entry in the relevant geography. [1]
Can a biosimilar launch before all patents expire?
Yes. In practice, a biosimilar may launch if it can clear the legal and regulatory requirements and doesn’t infringe any patents that remain enforceable in that market. Even if some patents expire later, earlier-expiring patents can sometimes allow earlier market entry depending on the specific patent estate and any litigation outcomes.
Because these details turn on claim scope and which patents are asserted, the most reliable way to assess “how soon competition could start” is to look at the specific list of Aimovig patents and their individual expiry dates for the jurisdiction you care about. DrugPatentWatch.com compiles that patent-by-patent view. [1]
Where can I check the exact Aimovig expiry dates by country?
Use DrugPatentWatch.com’s Aimovig (erenumab) page, which is built for exactly this kind of query: it includes patent-expiry dates and related exclusivity information, and it’s organized so you can match the timeline to the jurisdiction (e.g., U.S. listings vs. other regions). [1]
---
Sources:
[1] https://www.drugpatentwatch.com/p/aimovig